EUVIMEDEUVIMED entdecken
Open Access

Outcomes of a UK day case shoulder arthroplasty pathway: Safety, patient satisfaction and cost-saving analysis

Sophie J Donoghue iD, James Allen, Luke Budworth, Andrew Murphy, Mark Brinsden, Paul Guyver

Shoulder & Elbow · 04.03.2026

DOI: 10.1177/17585732261425939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Shoulder & Elbow, online erschienen am 04.03.2026. Verfasst von Sophie J Donoghue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma & Orthopaedics, University Hospitals Plymouth NHS Trust, Plymouth, UK. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elective shoulder arthroplasty waiting list times are increasing. Day case shoulder arthroplasty (DCSA) could help address this. This study aimed to review the safety, cost savings and patient satisfaction of a DCSA pathway introduced in May 2021.

Methods

All elective shoulder arthroplasties over three years (May 2021–2024) at a single centre were prospectively collected and retrospectively analysed. Two cohorts were compared: DCSA and inpatient. Primary outcomes were 90-day readmission and complication rates. Secondary outcomes were estimated cost savings and patient satisfaction using a locally developed non-validated questionnaire.

Results

Of 102 shoulder arthroplasties, 25 were DCSA and 77 were inpatients. DCSA patients were significantly younger (mean age 64.8 vs. 73.6 years; p < 0.001) and more likely to have ASA I status (16% vs. 6%; odds ratio (OR) 2.74, 95% confidence interval (CI) 0.68–11.14; p = 0.04). There were no significant differences in 90-day complications (4% vs. 9%; OR 0.42, 95% CI 0.05–3.56; p = 0.42) or readmissions (0% vs. 2%; OR 0.42, 95% CI 0.05–3.56; p = 1.00). All DCSA patients reported treatment success and were six times more likely to recommend it. Estimated cost savings were £10,262.75, with £37,766.92 potentially saved if all patients had undergone DCSA.

Conclusion

DCSA is safe, cost saving, and has high patient satisfaction. DCSA could be more widely adopted across the UK.

Schlagwörter

Stichwörter der Autor:innen

Shoulder arthroplastyambulatory shoulder replacementday case shoulder arthroplastyoutpatient shoulder arthroplastyshoulder replacement

Autor:innen und Institutionen

  • Department of Trauma & Orthopaedics, University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Department of Trauma & Orthopaedics, Royal Cornwall Hospitals NHS Trust, Truro, UK.
  • Department of Trauma & Orthopaedics, Leeds General Infirmary, UK.
  • University of Leeds, Leeds, UK.

ORCID-Profile: Sophie J Donoghue

Zitieren

APA

Donoghue, S. J., Allen, J., Budworth, L., Murphy, A., Brinsden, M., & Guyver, P. (2026). Outcomes of a UK day case shoulder arthroplasty pathway: Safety, patient satisfaction and cost-saving analysis. Shoulder & Elbow. https://doi.org/10.1177/17585732261425939

Vancouver

Donoghue SJ, Allen J, Budworth L, Murphy A, Brinsden M, Guyver P. Outcomes of a UK day case shoulder arthroplasty pathway: Safety, patient satisfaction and cost-saving analysis. Shoulder & Elbow. 2026. doi:10.1177/17585732261425939

BibTeX
@article{Donoghue2026,
  author = {Donoghue, Sophie J and Allen, James and Budworth, Luke and Murphy, Andrew and Brinsden, Mark and Guyver, Paul},
  title = {Outcomes of a UK day case shoulder arthroplasty pathway: Safety, patient satisfaction and cost-saving analysis},
  journal = {Shoulder & Elbow},
  year = {2026},
  doi = {10.1177/17585732261425939}
}
Kostenlos starten →